Shoulder mobility after axillary sentinel node biopsy for early infiltrating breast cancer treatment

It is known that complete axillary lymph node dissection for breast cancer treatment causes more frequent sensitive and motor alterations in the homolateral shoulder and upper limb than sentinel lymph node (SLN) biopsy. However, it is not clear how often patients treated by SLN biopsy suffer from shoulder mobility (SM) restriction, as well as its severity and duration. This study was done aiming to evaluate SM in 38 patients with early infiltrating breast cancer treated by SLN biopsy in whom shoulder movements were assessed before surgery and repeated at one, two and three months later. Shoulder-arm mobility was evaluated by goniometry considering flexion, abduction, aduction, extension, internal rotation and external rotation. An abnormal result for each movement was defined by restriction greater than ten degrees compared to preoperative findings. Significant abnormal results for flexion and abduction were found in all of the patients at the first month evaluation. At the third month assessment no women showed any kind of SM impairment. The average restriction evolution for each of the parameters is presented. It is concluded that there is frequently a slight and transient SM limitation in patients undergoing SLN biopsy. Early postoperative physiotherapeutical assistance should thus be advisable to relieve and shorten disability symptomatology.

Breast cancer; Sentinel node biopsy; Morbidity.

[1] Boyle P., Perlay J.: “Cancer incidence and mortality in Europe 2004”. Ann. Oncol., 2005, 16, 481.

[2] Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M.J.: “Cancer statistics 2007”. CA Cancer J. Clin., 2007, 57, 43.

[3] Paim S.J., Barber R.W., Solank C.K., Ballinger J.R., Britton T.B., Mortimer P.S. et al.: “Short-term effects of axillary lymph node clearance surgery on lymphatic physiology of the arm in breast cancer”. J. Appl. Physiol., 2005, 99, 2435.

[4] Leidenius M., Leppänem E., Krogerus L., Smitten M.D.: “Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer”. Am. J. Surg., 2003, 185, 127.

[5] Roses D.F., Brooks A.D., Harris M.N., Sharipo R.L., Mitnick J.: “Complications of level I and II axillary dissection in the treatment of carcinoma of the breast”. Ann. Surg., 1999, 230, 194.

[6] Krag O., Weaver D., Ashikaga T., Moffat F., Klimberg V.S., Shriver C. et al.: “The sentinel node in breast cancer - a multicenter validation study”. N. Engl. J. Med., 1998, 339, 941.

[7] Guiliano A.E., Jones R.C., Brennan M., Statman R.: “Sentinel lymphadenectomy in breast cancer”. J. Clin. Oncol., 1997, 15, 2345.

[8] Lyman G.H., Giuliano A.E., Somerfield M.R., Benson A.B. 3rd, Bodurka D.C., Burstein H.J. et al.: “American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer”. J. Clin. Oncol., 2005, 23, 1.

[9] Veronesi U., Paganelli G., Viale G., Luini A., Zurrida S., Galimberti V. et al.: “Sentinel – lymph node biopsy a staging procedure in breast cancer: update of a randomized controlled study”. Lancet Oncol., 2006, 7, 983.

[10] Barros A.C.D.S., Barros M.A.C., Andrade F.E., Mori L., Costa P. A., Pelizon C. et al.: “Combined radioguided nonpalpable lesion localization and sentinel lymph node biopsy for early breast carci-noma”. Ann. Surg. Oncol., 2007, 14, 1472.

[11] Luin I.A., Zurrida S., Galimberti V., Paganelli G.: “Radioguided surgery of occult breast lesions”. Eur. J. Cancer, 1998, 34, 204.

[12] Barros A.C.S.D., Cardoso M.A., Sheng P.Y., Costa P.A., Pelizon C.: “Radioguided localization of nonpalpable breast lesions and simultaneous sentinel lymph node mapping”. Eur. J. Nucl. Med. Mol. Imag., 2002, 29, 1561.

[13] Langer I., Guller U., Berclaz G., Koechli O.R., Schaer G., Fehr M. K. et al.: “Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery. A prospective Swiss multicenter study on 659 patients”. Ann. Surg., 2007, 245, 452.

[14] Swenson K.K., Nissen M.J., Ceronsky C., Swenson L., Lee M.W:, Tuttle T.M.: “Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer”. Ann. Surg. Oncol., 2002, 9, 745.

[15] Purushotham A.D., Upponi S., Klesevath M.B., Bobrow L., Millar K., Myles J.P. et al.: “Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomised controlled trial”. J. Clin. Oncol., 2005, 23, 4312.

[16] Schulze T., Mucke J., Markwart J., Schilag P.M., Bembenek A.: “Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection”. J. Surg. Oncol., 2006, 93, 109.

[17] Silberman A.W., Macvay C., Cohen J.S., Altura J.F., Brackert S., Sarna G.P. et al.: “Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique”. Arch. Surg., 2004, 240, 1.

[18] Sugden E.M., Rezvani M., Harrison J.M., Hughes L.K.: “Shoulder movement after the treament of early stage breast cancer”. Clin. Oncol., 1998, 10, 173.

[19] Voogd A.C., Ververs J.M.M.A., Vingerhoets A.J.J.M., Roumen R. M., Coebergh J.W.W, Crommelin M.A.: “Lymphoedema and reduced shoulder function as indicators of quality of life after axil-lary lymph node dissection for invasive breast cancer”. Br. J. Surg., 2003, 90, 76.

[20] Haid A., Kuenh T., Konstantiniuk P., Koberle-Wuhrer R., Knauner M., Kreienberg R.: “Shoulder arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer”. Eur. J. Oncol., 2002, 28, 705.

[21] Mansel R.E., Fallowfield L., Kissin M. et al.: “Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial”. J. Natl. Cancer Inst., 2006, 98, 599.

[22] Schrenk P., Rieger R., Shami-yeh A., Wayand W.: “Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma”. Cancer, 2000, 88, 608.

[23] McCarter M.D., Yeung Y., Fey J., Borgen P.I., Cody H.S. 3rd: “The breast cancer patient with multiple sentinel nodes: when to stop?”. J. Am. Coll. Surg., 2001, 192, 692.

[24] Kuhen T., Vogl F.D., Helms G., Whitworth P.W., Leitch A.M., Reintgen D.S. et al.: “Sentinel-node biopsy for axillary staging in breast cancer: results from a large prospective German multi-institutional trial”. Eur. J. Surg. Oncol., 2004, 30, 252.

[25] Wilke L.G., McCall L.M., Posther K.E., Whitworth P.W., Reint-gen D.S., Leitch A.M., Gabram S.G. et al.: “Surgical complications associated with sentinel node biopsy: results from a prospec-tive international cooperative group trial”. Ann. Surg. Oncol., 2006, 13, 1491.

[26] Rietman J.S., Dijkstra P.U., Geertzeu J.H.B., Hoeskstrat H.J., Eisma W.H., Szabo B.G. et al.: “Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma”. Cancer, 2003, 98, 690.

[27] Box R.C., Hildergard M.R.H., Bullock-Saxton J.E., Furnival C. M.: “Shoulder movement after breast cancer surgery: results of a randomized controlled study of postoperative physiotherapy”. Breast Cancer Res. Treat., 2002, 75, 35.